Comparison of cardiovascular outcomes in patients with diabetes treated with tirzepatide versus semaglutide: a multi-institutional analysis
31 August 2024 (16:00 - 16:50)
Organised by: 
About the speaker
Baylor University Medical Center, Dallas (United States of America)
8 More presentations in this session
Associate Professor M. Cavender (Chapel Hill, US)
DNA methylation in the TXNIP gene is associated with type 2 diabetes in Pacific Peoples living in NZ
Mr S. Gibbs (Christchurch, NZ)
Professor M. Matshela (Durban, ZA)
Access the full session
The Event
ESC Congress 2024
31 August 2024
16:00 CET
You may be interested in
Congress Session
